Salarius Pharmaceuticals, Inc.

DB:FP10 Stock Report

Market Cap: €2.0m

Salarius Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FP10?
Owner TypeNumber of SharesOwnership Percentage
Institutions31,1982.16%
Individual Insiders36,2782.52%
General Public1,373,68195.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 216.6%.

Top Shareholders

Top 22 shareholders own 4.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
1.77%
Elvin Lee
25,534€34.9k0%no data
1.58%
Armistice Capital LLC
22,750€31.1k117%no data
0.43%
David Arthur
6,142€8.4k0%no data
0.22%
Tower Research Capital Europe Limited
3,178€4.3k202%no data
0.21%
Geode Capital Management, LLC
3,096€4.2k0%no data
0.19%
Mark Rosenblum
2,731€3.7k0%no data
0.13%
The Vanguard Group, Inc.
1,820€2.5k0%no data
0.029%
Arnold Hanish
412€563.60%no data
0.026%
Jonathan Lieber
368€503.40%no data
0.025%
William McVicar
356€486.90%no data
0.024%
Tess Burleson
340€465.00%no data
0.015%
Paul Lammers
215€294.10%no data
0.012%
Bruce McCreedy
180€246.2-19.6%no data
0.011%
Woodbury Financial Services, Inc, Securities Investments
163€222.90%no data
0.0078%
UBS Asset Management AG
113€154.55,550%no data
0.0037%
Advisor Group Holdings, Inc., Asset Management Arm
53€72.50%no data
0.00069%
Securities America Advisors, Inc.
10€13.60%no data
0.00049%
Morgan Stanley, Investment Banking and Brokerage Investments
7€9.70%no data
0.00028%
Bank of America Corporation, Asset Management Arm
4€5.50%no data
0.00014%
Merrill Lynch & Co. Inc., Banking Investments
2€2.80%no data
0.00007%
BlackRock, Inc.
1€1.40%no data
0.00007%
Wells Fargo & Company, Securities and Brokerage Investments
1€1.40%no data